Arash Naeim, MD, PhD
Dr. Arash Naeim is trained in health services research with an emphasis in cost-effectiveness and decision-making in older cancer patients, and his research focuses on aging and cancer. In recent years, Naeim also has been involved in developing informatics in hematology/oncology. He has an interest in how electronic databases and medical records can be used in outcomes research, patient/physician education and healthcare interventions.
Naeim A, Wong FL, Pal SK, Hurria A. Oncologists' recommendations for adjuvant therapy in hormone receptor-positive breast cancer patients of varying age and health status. Clin Breast Cancer. 2010 Apr;10(2):136-43.
Hurria A, Wong FL, Pal S, Chung CT, Bhatia S, Mortimer J, Somlo G, Hurvitz S, Villaluna D, Naeim A. Perspectives and attitudes on the use of adjuvant chemotherapy and trastuzumab in older adults with HER-2+ breast cancer: a survey of oncologists. Oncologist. 2009 Sep;14(9):883-90. Epub 2009 Sep 2
Naeim A, Keeler E, Bassett LW, Parikh J, Bastani R, Reuben DB. Cost-effectiveness of increasing access to mammography through mobile mammography for older women. J Am Geriatr Soc. 2009 Feb;57(2):285-90. Epub 2008 Dec 11
Naeim A, Sawhney R, MacLean CH, Sanati H. Quality indicators for the care of breast cancer in vulnerable elders. J Am Geriatr Soc. 2007 Oct;55 Suppl 2:S258-69.
Naeim A, Hurria A, Leake B, Maly RC. Do age and ethnicity predict breast cancer treatment received? A cross-sectional urban population based study. Breast cancer treatment: age and ethnicity. Crit Rev Oncol Hematol. 2006 Sep;59(3):234-42. Epub 2006 Jul 10